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Abstract
Background 22q11 deletion syndrome (22q11DS) is
associated with mild or borderline intellectual dis-
ability (ID). There are hardly any reports on sub-
jects with 22q11DS with moderate or severe ID,
and therefore its behavioural and psychiatric charac-
teristics are unknown.
Method We describe behavioural and psychiatric
characteristics of 33 adults with 22q11DS and a
Full-Scale IQ (FSIQ) below 55. Participants were
divided into two groups: one group having a
FSIQ ≤ 55 caused by intellectual decline (n = 21)
and one group with a FSIQ ≤ 55 who had always
functioned at this level (n = 12).
Results High scores on psychopathology sub-scales
were found for both subgroups. 22q11DS patients
with intellectual decline showed higher rates of
co-morbid psychopathology, particularly psychosis.
Furthermore, psychosis and intellectual decline
were positive correlated.
Conclusion This is the first report addressing adult
patients with 22q11DS and moderate to severe ID.
Overall we found high levels of psychopathology
with higher scores of psychopathology in the intel-
lectual decline group. Life time psychosis seems to
be related to deterioration.
Keywords 22q11 deletion syndrome, intellectual
decline, IQ, psychopathology, velocardiofacial
syndrome
Introduction
22q11 deletion syndrome (22q11DS), is the most
common recurrent copy-number variant disorder
caused by a microdeletion in chromosome band
22q11.2 occurring with an incidence of 1 in 4000
(Oskarsdottir et al. 2004; McDonald McGinn &
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Sullivan 2011). It is also known as Shprintzen’s
syndrome or velocardiofacial syndrome (VCFS).
Earlier reports of conotruncal anomaly face syn-
drome, Cayler’s syndrome, Takao’s syndrome,
Sedlačková syndrome, velofacial syndrome and
Di-George syndrome turned out to be caused by
the same deletion (McDonald McGinn & Sullivan
2011). Characteristic clinical features include palatal
anomalies, cardiac anomalies, hypo- or aplasia of
the thymus, hypoplasia of the parathyroid and
typical facial features. The physical appearance is
known to be highly variable (McDonald-McGinn
et al. 1999; Shprintzen et al. 2005; Shprintzen
2008). Approximately half of all subjects with
22q11DS have a normal to borderline intelligence
(Swillen et al. 1997; Henry et al. 2002; Antshel et al.
2008; Niklasson & Gillberg 2010) and if an intellec-
tual disability (ID) is present, this is usually mild
(Swillen et al. 1997; De Smedt et al. 2007). The
presence of a severe or profound ID is thought to
be rare (Swillen et al. 1997). Patients with 22q11DS
have a characteristic intelligence profile with poor
visual spatial skills, planning ability and abstract
reasoning (Swillen et al. 1999; Henry et al. 2002).
Besides the physical and intellectual characteristics,
several psychiatric disorders have been reported to
be common in children and adolescents with
22q11DS including autism spectrum disorders
(ASD) (14%–50%), attention-deficit/hyperactivity
disorder (ADHD) (3%–46%), specific and social
phobias (23%–61%), generalised anxiety disorder
(17%–29%), separation anxiety disorder (16%–
21%), oppositional defiant disorder (16%–21%),
obsessive-compulsive disorder (OCD) (4%–33%),
major depressive disorder and dysthymia (10%–
20%) and bipolar disorder (0–64%) (Papolos et al.
1996; Arnold et al. 2001; Feinstein et al. 2002;
Gothelf et al. 2004, 2009; Antshel et al. 2006, 2007;
Vorstman et al. 2006; Niklasson et al. 2009;
McDonald McGinn & Sullivan 2011; Philip &
Bassett 2011). Up to 30% of the patients with
22q11DS develop psychotic disorders including
schizoaffective disorder and schizophrenia in late
adolescence and early adulthood (Murphy et al.
1999; Bassett et al. 2003; Gothelf et al. 2005, 2009;
Stevens & Murphy 2005; Boot et al. 2011b). There-
fore, studying this syndrome offers a unique oppor-
tunity to increase our understanding of the
mechanisms underlying psychiatric disorders. Only
few patients with 22q11DS and moderate to severe
ID [Full-Scale IQ (FSIQ) < 55] have been described
in the literature (Gerdes et al. 1999; Evers et al.
2009). The aim of this explorative study was to gain
a better insight into the psychiatric phenotype in
adults with 22q11DS who are functioning in the
moderate to severe ID range. This will expand our
knowledge on the cognitive and psychiatric pheno-
type of 22q11DS. In addition it may aid the clini-
cian who is working with these often challenging
patients.
Method
The study was approved by the Medical Ethics
Committee of the University of Maastricht, Maas-
tricht, the Netherlands.
Study population
Participants were recruited through a Dutch psychi-
atric 22q11DS outpatient clinic and through physi-
cians specialised in ID. Subjects with a confirmed
deletion in chromosome band 22q11.2 and a
present FSIQ ≤ 55 were included. Those aged under
18 years and over the age of 65 years were excluded,
as well as participants with physical disorders affect-
ing brain function like suspicion of major neurologi-
cal disorders like brain tumours or stroke. A
number of participants gave written consent, and
where participants were not able to do so (the
majority), consent was obtained from caregivers.
Thirty-three participants [15 women (45.5%), 18
men (54.5%)] with confirmed 22q11DS participated
in this study. The mean age of participants was 40
years (SD = 11, range 19–59 years). Thirty-one
(93.9%) of the participants lived in institutions
and 6.1% (n = 2) lived at home with their family.
Socio-demographic characteristics are presented in
Table 1. All participants had a present level of
functioning below FSIQ 55. Presence of psychosis
during life was obtained out of data from medical
files and/or positive score for psychosis on the Mini
PAS-ADD (Psychiatric Assessment Schedules
for Adults with Developmental Disabilities).
Premorbid intellectual functioning was determined
preferable at young adult age by data from medical
files. Based on premorbid intellectual functioning
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subjects were divided into two groups: an ‘intellec-
tual decline group’ (n = 21): patients with a
FSIQ > 55 in the past, but who were functioning at
a level of FSIQ ≤ 55 at time of inclusion, and a ‘no
intellectual decline group’ (n = 12): patients with a
FSIQ ≤ 55 who had a premorbid FSIQ ≤ 55.
Clinical and behavioural measures
The individuals with 22q11DS and their main
caretakers were visited at home. They were inter-
viewed by a psychiatrist with special expertise in ID
(lead author). The following instruments were
administered:
Vineland-screener
The translated version (Dutch) of the Vineland
screener (Vineland-S) (Scholte et al. 2008) was
used to obtain information about adaptive func-
tioning. It is developed for children, adolescents
and adults with a developmental age up to 6 year.
It is suitable for use in both research and clinical
settings (Sparrow et al. 2008). This instrument,
completed by a primary caregiver, provides a prac-
tical indication of the adaptive functioning related
to age (van Duijn et al. 2009). Vineland instru-
ments have been used in adults with a moderate
to severe ID and various genetic disorders
(Wulffaert et al. 2009; Adams & Oliver 2010).
Because standard intelligence instruments are not
suitable in this range of intelligence we chose for
the Vineland screener. Outcomes of the
Vineland-S developmental age were used to give
an estimation of FSIQ (Kraijer & Plas 2006).
Comparison of intelligence measured with
Wechsler scales and functioning determined with
Vineland screener has been described before in
22q11DS (Antshel et al. 2005). Internal consistency
of this instrument (Cronbach’s alpha) varied from
0.96 to 0.99 with a test–retest correlation varying





(n = 12) P-values
Gender Male: 10; female: 11 Male: 8; female: 4 0.305
Age: mean ± SD 41.81 ± 7.393 39.00 ± 14.87 0.550
Premorbid IQ: mean ± SD 74.2 ± 7.5 43.7 ± 8.1 0.000*
Age at assessment of premorbid IQ: mean ± SD (range) 18.2 ± 6.8 (6–27) 17.5 ± 6.9 (7–32) 0.769
Duration between assessment of premorbid functioning
and present assessment: mean ± SD (range)
23.6 ± 9.8 (8–39) 21.5 ± 11.4 (14–48) 0.585
V-S, communication: mean ± SD† 44.2 ± 15,3 35.2 ± 15.9 0.117
V-S, daily living skills: mean ± SD† 48.9 ± 13.5 45.8 ± 16.8 0.565
V-S, socialisation: mean ± SD† 23.3 ± 10.3 27.3 ± 16.6 0.398
V-S, motor skills: mean ± SD† 38.2 ± 13.0 33.6 ± 14.1 0.345
V-S, composite score: mean ± SD† 39.4 ± 12.1 35.3 ± 15.6 0.406
Estimated FSIQ (Vineland-S composite scores): mean ± SD 30.2 ± 8.0 27.3 ± 10.7 0.383
FSIQ drop‡: mean ± SD 43.1 ± 14.0 15.3 ± 8.4 0.000*
History of Psychotic Disorder 20 (95%) 2 (15%) 0.000*
Use of antipsychotics 17 (81%) 7 (58%) 0.171
Use of antidepressants 6 (29%) 3 (25%) 0.831
Use of mood stabilisers 11 (52%) 4 (33%) 0.305




* P-value ≤ 0.007 (after Bonferroni adjustment).
† Vineland-S, in developmental age (in months).
‡ Drop Full-Scale IQ (FSIQ): premorbid FSIQ minus estimated FSIQ based on Vineland-S scores.
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Mini PAS-ADD
The Mini PAS-ADD, a semi-structured interview
for psychiatric disorders in people with an
ID (Prosser et al. 1998), was used to provide reli-
able information on symptoms and to obtain psy-
chiatric diagnoses. Outcomes scores can be
dichotomised applying threshold scores when
indicative for diagnosis (see Table 2). All inter-
views were carried out by an experienced psychia-
trist (lead author). Recent research into the
psychometric properties showed the sensitivity to
be 100% and the specificity to be 77% (Devine
et al. 2010). Cronbach’s alpha varied from 0.55 for
unspecified disorders to 0.95 for autism (Prosser
et al. 1998).
Adult Behavioral Check List (ABCL)
The Adult Behavioral Check List (ABCL)
(Achenbach & Rescorla 2003) was administered to
assess prevalence and severity of any behavioural
problems. The 134-item questionnaire was com-
pleted by the primary caregivers of the participants.
Problematic statements were scored by a carer or
family member who knew the person well, on a
three-level rating scale (‘not true’, ‘somewhat or
sometimes true’ and ‘very true’). Following analysis,
eight syndrome scales were distinguished (anxious/
depressed, withdrawn, somatic complaints, thought
problems, attention problems, aggressive behaviour,
rule-breaking behaviour and intrusive) and six
DSM-oriented (Diagnostic and Statistical Manual





mean ± SD P-value
Depression (10) 8.38 ± 7.24 3.33 ± 3.11 0.010
Anxiety disorder (7) 3.81 ± 4.86 0.83 ± 2.04 0.020
Mania/hypomania (8) 2.14 ± 2.50 0.75 ± 0.75 0.070
Obsessive-compulsive disorder (3) 1.29 ± 1.95 0.50 ± 1.45 0.234
Psychosis (2) 2.00 ± 2.15 0.25 ± 0.62 0.002*
Unspecified (6) 3.29 ± 2.43 0.58 ± 0.79 0.000*
Autism spectrum N (4) 5.81 ± 1.60 5.33 ± 1.92 0.450
Autism spectrum P (1) 1.57 ± 0.87 1.42 ± 0.79 0.616
Autism spectrum R (3) 1.43 ± 0.98 1.42 ± 1.08 0.974
ABCL/syndrome scale‡
Anxious/depressed 67.43 ± 14.28# 60.50 ± 8.12 0.134
Withdrawn 75.38 ± 11.05## 70.92 ± 6.37## 0.151
somatic complaints 59.48 ± 6.20 59.67 ± 7.68 0.938
Thought problems 74.10 ± 9.23## 69.75 ± 14.05# 0.291
Attention problems 71.52 ± 8.52## 65.17 ± 6.85# 0.035
Aggressive behaviour 69.33 ± 13.26# 62.75 ± 21.02 0.277
Rule breaking behaviour 64.71 ± 6.57 61.00 ± 4.79 0.097
Intrusive 60.76 ± 10.20 59.75 ± 7.55 0.767
ABCL/DSM oriented scale‡
Depressive problems 67.86 ± 9.99# 63.33 ± 8.86 0.203
Anxiety problems 59.10 ± 9.46 57.75 ± 9.42 0.697
Somatic problems 58.19 ± 6.88 59.25 ± 7.68 0.686
Avoidant problems 73.10 ± 9.03## 69.58 ± 4.68# 0.152
ADHD problems 67.90 ± 10.22# 62.83 ± 6.85 0.136
Antisocial problems 65.14 ± 8.97# 60.67 ± 8.96 0.178
* P ≤ 0.002 (after Bonferroni adjustment).
† In brackets: threshold score when indicative for diagnosis.
‡ ABCL scores: <65: normal; 65–70: borderline clinical range#; >70: clinical range##.
Mini PAS-ADD, Mini Psychiatric Assessment Schedules for Adults with Developmental Disabilities; ABCL, Adult Behavioral Check List;
DSM, Diagnostic and Statistical Manual of Mental Disorders; ADHD, attention-deficit/hyperactivity disorder.
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of Mental Disorders) scales: depressive problems,
anxiety problems, somatic problems, avoidant per-
sonality problems, ADHD problems and antisocial
personality problems). Internal consistency of the
ABCL (Cronbach’s alpha) varied from 0.70 to 0.97
with a test–retest correlation varying 0.73 and 0.92
(Achenbach & Rescorla 2003).
Use of psychotropic drugs
The use of psychotropic drugs was noted and classi-
fied as antipsychotics, antidepressants and mood
stabilisers (Table 1).
Statistical analyses
Socio-demographic data were examined using inde-
pendent t-tests and Chi-square analysis to deter-
mine whether both groups differed with regards to
age, gender and present FSIQ. Between-group com-
parisons were carried out to investigate differences
between the deterioration group and the stable low
IQ group. We used independent t-tests for all scores
on the Mini PAS-ADD and ABCL that met criteria
for a normal distribution. Mann–Whitney U-tests
were used in case scores were not normally distrib-
uted. To correct for multiple comparisons
(Bonferroni adjustment) the significance level for
testing was set at α = 0.007 (demographics) and
α = 0.002 (Mini PAS-ADD and ABCL). A two-
way between-group analysis of variance was con-
ducted to explore the impact of gender on
outcomes of psychopathology in both groups. For
the correlation presence of psychosis during life and
IQ drop and the correlation between present IQ
and use of antipsychotics we performed a Spearman
Rank Order correlation coefficient. Pearson
product–moment correlation coefficients were per-
formed to analyse (1) the relation between the inter-
val between first intellectual assessment and present
intellectual assessment and extend of intellectual
decline, and (2) the relation of present FSIQ and
Mini PAS-ADD scores for depression, psychosis,
anxiety and unspecified problems.
Results
Participants
There were no significant between-group differences
in gender, age and recently estimated FSIQ
(Table 1). Eighteen subjects out of 21 (86%) of
the deterioration group were on antipsychotic
medication; in the stable low IQ group 6 out of 12
subjects (50%) took antipsychotic medication
(P = 0.027).
Figure 1 shows distributions of decline in individ-
uals of the two groups showing that they are distinct
groups.
Previous methods of intelligence assessment
Of eight patients (all in the ‘intellectual decline’
group) intelligence tests were not available. Their
premorbid intelligence was very conservative esti-
mated based on their school and/or work history. Of
12 patients (five of the ‘intellectual decline’ group
and seven of the ‘intellectual stable’ group) intelli-
gence was assessed with a variety of test including
WISC (n = 5), Vineland (n = 1), GIT (n = 1),
WAIS (n = 3), Peabody (n = 1) and WPPSI (n = 1).
Of 13 patients (eight of the ‘intellectual decline’
group and five out of the ‘intellectual stable’ group)
an IQ score was found in medical files, but no
method was mentioned.
Psychopathology (Table 2)
Scores on the Mini PAS-ADD show that symp-
toms of depressive, psychotic and unspecified
disorders were significantly more present in the
deterioration group. The symptoms of anxiety
disorders on the Mini PAS-ADD (P = 0.02) and
attention problems on the ABCL (P = 0.035) were
marginally significant between the two groups, all
symptoms occurring more often in the deteriora-
tion group. Those with cognitive deterioration
were more likely to have a history of a psychotic
disorder (P = 0.000). The relation between life-
time psychosis (yes/no) and IQ drop was investi-
gated using Spearman Rank Order correlation
coefficient. There was a strong positive correlation
between the two variables, rho = 0.662, n = 33,
P = 0.000, with presence of lifetime psychosis
associated with a larger levels of IQ drop. The
relation between present FSIQ and psychopathol-
ogy was investigated using a Pearson product–
moment correlation coefficient between the Mini
PASS-ADD scores depression, anxiety, psychosis
and unspecified problems (those scored in clinical
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ranges) with present FSIQ. None of them showed
a correlation (r = 0.257, P = 0.149; r = 0.066,
P = 0.716; r = 0.332, P = 0.059; r = 0.047,
P = 0.796).
Gender differences
On the ABCL we found a significant group by
gender interaction for aggressive behaviour
(P = 0.015). In the ‘intellectual decline’ group men
showed less aggression (P = 0.04) compared with
women, whereas in the ‘no intellectual decline’
group there were no gender differences on ABCL
scores. In the ‘intellectual decline’ group women
scored higher on psychotic symptoms compared
with men (P = 0.021), whereas in the ‘no intellec-
tual decline’ group there was no difference
between men and women. In addition, there was a
significant group by gender interaction for the
ASS-N score (Autism Spectrum Score — social
interaction) (P = 0.026), female in the intellectual
decline group showed less social interaction prob-
lems compared with the female in the no intellec-
tual decline group, and the men in the
deterioration group scored showed more social
interaction problems compared with the men in de
‘no intellectual decline’ group.
IQ drop
The relation between the interval of the first assess-
ment and present assessment and extend of decline
was investigated using Pearson product–moment
correlation coefficient. There was a strong positive
relation (r = 0.38, P = 0.027) when performed in
all 33 patients. When performed only on the ‘intel-
lectual decline group’ the correlation increases
(r = 0.51, P = 0.017). Correlation in the ‘no intel-
lectual decline’ group was not significant (r = 0.48,
P = 0.112).
Discussion
This is the first study that describes psychopathol-
ogy in patients with 22q11DS and a moderate to
profound ID.
Psychopathology
Overall we found high levels of psychopathology.
However when dividing the group in those who
with premorbid IQ < 55 and those with premorbid
IQ > 70 and subsequent cognitive decline we
observed more psychopathology in the latter group.
On the Mini PAS-ADD, a striking difference was
Figure 1 Scatter plot showing Full-Scale
IQ (FSIQ) decline in two groups.
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observed between the two groups for symptoms of
depression, psychosis and unspecified disorders
(including memory and concentration problems,
restlessness, sleep problems and anhedonia), with
scores being significantly higher in the deterioration
group. Scores on the ABCL, however, did not reach
significant differences between both groups for
depressive and thought problems. One of the
reasons for this may be that the ABCL does not
score for the same clusters as the Mini PAS-ADD.
Items scoring for depression and anxiety can mimic
symptoms as seen in ASD. We found high scores
on the Mini PAS-ADD in domains of ASD in both
groups (up to 92%), especially on social interaction
scale (scale N of the Mini PAS-ADD) and commu-
nication problems (scale P of the Mini PAS-ADD),
which is higher than reported in previous studies
(44%–50%) (Vorstman et al. 2006; Niklasson et al.
2009) which were all done in children with
22q11DS. High scores on scale R of the ASD
domains on the Mini PAS-ADD (repetitive and ste-
reotype behaviour) were less common than social
interaction problems and communication problems.
Bruining et al. (2010) suggested that ASD in
22q11DS shows less autistic symptom variance
compared with ASD not associated with 22q11DS.
They suggest that the influence of a specific genetic
variant (such as 22q11DS) leads to a typical ASD
subtype with lower autistic symptom variance. The
findings in this study give support to this lower
symptom variance within 22q11DS, with high scores
in the social interaction and communication scales,
and low scores on ritualistic behaviour on the Mini
PAS-ADD.
We found higher scores on psychopathology in
the deterioration group and less psychopathology in
the stable low IQ group. In a cohort of 75 children
with non-specific ID, Koskentausta et al. (2007),
found more psychopathology in moderately intellec-
tually disabled children when compared with
severely/profoundly intellectually disabled children.
Chadwick et al. (2008) also found a positive associa-
tion between psychopathology and severity of ID in
people with non-specific ID although the severity of
the ID was also positively associated with autistic
symptomatology. We did not conduct a longitudinal
study, but retrospective data analysis showed fewer
lifetime psychotic problems in the stable low IQ
group. This is in agreement with the study of
Horovitz et al. (2011) who found a stable pattern of
psychopathology in 74 adults with a severe to pro-
found ID (in non-specific intellectual disabled
adults) over a period of 1 year.
Low FSIQ and deterioration
The average premorbid FSIQ of 74.2 (±7.5) in our
deterioration group is within the range of intelli-
gence normally found in children and adults with
22q11DS (Swillen et al. 2000; Chow et al. 2006;
Vorstman et al. 2006). Cognitive deterioration in
schizophrenia is a common finding (Becker et al.
2010); however, in our study we found a more
severe decline in intellectual functioning compared
with cognitive deterioration typically found in
schizophrenia (Russell et al. 1997; Seidman et al.
2006). Low functioning is noted on all Vineland
domains demonstrating that not only verbal IQ is
declined as seen in earlier research in 22q11DS
(Woodin et al. 2001). Our data show a strong posi-
tive correlation between psychotic problems during
lifetime and deterioration in 22q11DS (r = 0.621,
P = 0.000). There was no significant correlation
between deterioration and current psychotic prob-
lems according to the Mini PAS-ADD score.
Therefore we presume a causal relationship between
lifetime psychosis and deterioration. To the best of
our knowledge only 2 case reports have reported the
phenomenon of severe cognitive deterioration in
adult 22q11DS (Evers et al. 2006, 2009). Duijff
et al. reported in children with 22q11DS between
5.5 and 9.5 years old a mean significant decline of
9.7 FSIQ points. Ten out of 29 children showed an
absolute decline in cognitive raw scores between
ages 7.5 and 9.5 year (Duijff et al. 2012). Gothelf
et al. (2005) observed a cognitive deterioration in
22q11DS, during childhood. This deterioration was
10 points in verbal IQ with a strong correlation
between the low activity Catechol-O-Methyl-
Transferase (COMT) genotype, psychosis and
deterioration. The relation between 22q11DS
and psychosis has received attention in recent
literature, where particularly COMT and Proline
Dehydrogenase (PRODH) genes, both located in
the deleted region, have been investigated (Raux
et al. 2007; Boot et al. 2011c; da Silva Alves et al.
2011; de Koning et al. 2012). Haplo-insufficiency of
COMT and/or PRODH genes could be a factor in
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the process of cognitive deterioration. We found a
very high prevalence of lifetime history of psychotic
problems (95%) in the deterioration group, com-
pared with the stable low IQ group (15%) and com-
pared with previous findings of up to 30% in people
with 22q11DS as a whole (Bassett et al. 2003). In
our study gender differences were found with the
female patients in the deterioration group showing
more aggression and being particularly more vulner-
able to develop a psychotic disorder when com-
pared with the stable low IQ group. Gender
differences in 22q11DS have been described before.
Kates et al. (2006) suggested that COMT polymor-
phism may have a gender modulating effect in
determining the neuroanatomical phenotype.
Antshel et al. (2005) found in a cohort of children
that boys may be more cognitively affected than
girls and a negative association between age and
cognitive functioning in girls with 22q11DS but not
in boys. Also Boot et al. found indications of a
slower dopamine metabolism in female patients
(Boot et al. 2011a). Oestrogens down-regulate
COMT activity, resulting in a lower COMT and
higher dopaminergic activity in women compared
with men (Chen et al. 2004). Therefore, effects of
COMT haplo-insufficiency may differentially affect
men and women in with 22q11DS (Harrison &
Tunbridge 2008).
In the analysis we looked for other possible expla-
nations for the observed decline. Medication could
be as one explanation for this decline; however, we
found no differences between the two groups. Also
a Spearman’s rho correlation coefficient showed no
significant level of correlation between present IQ
and use of antipsychotics. Active psychopathology
can have an impact on cognitive functioning and in
the intellectual decline group we observe a signifi-
cant higher proportion in depressive, anxiety, psy-
chotic and unspecified problems (the latter two still
significant after Bonferroni correction). Depression,
for instant, is known to have a serious impact on
daily functioning and it can be expected to influ-
ence scores on the Vineland-screener. To determine
if active psychopathology is correlated with the
present FSIQ we performed a Pearson product–
moment correlation coefficient between Mini PAS-
ADD scores for depression, psychosis, anxiety and
unspecified problems with present FSIQ. None of
them showed a significant correlation. At this
moment we presume a continuous, degenerative
process having a stable and severely impairing
impact on cognition and mental health.
Strength and limitations
This is the first report addressing adult patients with
22q11DS and moderate to severe ID. To date, most
studies in 22q11DS concern children, adolescents
and young adults. Also, subjects with moderate to
severe ID are often excluded from studies therefore
current literature on 22q11DS may not representa-
tive of the 22q11DS. Gaining more insight into pos-
sible prognostic outcomes is in our opinion very
important. This study, however has some limita-
tions. Although the sample size is relatively large
and the first for this specific subgroup of people
with 22q11DS, it is still small from a methodologi-
cal point of view. Additionally, most participants
were referred by psychiatric services or ID
physicians, which makes the study accessible to
ascertainment bias. Because of the low level of
intellectual functioning we were unable to measure
intelligence with standard intelligence tests.
Premorbid intellectual functioning was obtained
retrospectively from patient records. Therefore,
premorbid functioning was established with
different IQ instruments. Ideally, comparison of
premorbid with present functioning is done with the
same instruments. However, to our knowledge,
there are no instruments that can measure mild ID
and severe or profound disabilities making compari-
son possible. Establishing adaptive functioning with
Vineland-Screener and afterwards making an esti-
mation of present functioning was in our opinion
the best choice.
In this study we presented a series of 33 patients
who function at a low intelligence level. Some of
them functioned already at young age at that low
level, were others declined during adulthood.
Although an IQ below 55 was thought to be rela-
tively uncommon, but reported (Gerdes et al. 1999),
we showed that it may be more common than
expected. 22q11DS as a diagnosis should be consid-
ered when patients display intellectual decline, espe-
cially when accompanied by psychosis. Conditions
that are relative uncommon in 22q11DS, such as
polymicrogyria should not impede this (Robin et al.
2006). Our results suggest that those adults with
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22q11DS that gradually deteriorate cognitively are
highly likely to suffer from psychotic episodes
during adult life, whereas those with a premorbid
low IQ do not show the increased rates of psychosis
that usually is seen in 22q11DS.
The presence of psychosis and cognitive deterio-
ration suggests a Dementia Praecox like picture
as described by Kraepelin (Kraepelin 1901).
This psychotic disorder was described as a
neurodegenerative process resulting in a dementia-
like condition. The cognitive deterioration we found
in our 22q11DS sample may be more severe and
suggests a neurodegenerative process involving
genes located at 22q11.
More attention should be paid to psychiatric
examination of 22q11DS subjects with moderate to
severe ID. Longitudinal studies, including adult
ages are needed to gain more insight in the behav-
ioural, cognitive and psychiatric problems of this
specific subgroup.
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